U.S. Entertainment Stock News

NYSE:PLNT
NYSE:PLNTHospitality

Does Planet Fitness' (PLNT) CFO Shake-Up Test or Reinforce Its Management Credibility Narrative?

On March 9, 2026, Planet Fitness announced that former CFO Tom Fitzgerald returned as Interim CFO following the same-day departure of CFO Jay Stasz, while the company reiterated its previously issued 2026 financial guidance. This leadership change brings back an executive deeply familiar with Planet Fitness’s franchise model, capital allocation approach, and prior acquisition activity, potentially supporting operational continuity. Now we’ll examine how Fitzgerald’s interim return and the...
NYSE:CNX
NYSE:CNXOil and Gas

Is CNX’s Earnings Momentum and Insider Activity Altering The Investment Case For CNX Resources (CNX)?

In recent weeks, CNX Resources has been featured in growth-focused stock screens and analyst commentary for its improving financial results, consistent earnings outperformance, and expanding profit margins, while its CFO Everett Good gained industry recognition from the Pittsburgh Business Times. At the same time, the company’s combination of strong sales growth, solid returns on equity, and positive technical momentum has sharpened investor attention on how CNX’s fundamentals align with...
NYSE:XPRO
NYSE:XPROEnergy Services

Why Expro Group Holdings (XPRO) Is Down 5.0% After Analyst Downgrade On Flat 2026 Outlook - And What's Next

Earlier in March, Freedom Capital analyst Sergey Pigarev downgraded Expro Group Holdings N.V. to Sell from Hold following its fiscal Q4 2025 results and management’s guidance for flat 2026 revenue amid softer global drilling activity and weaker oil prices. The downgrade highlights how Expro’s sensitivity to shifts in drilling demand and commodity prices can quickly influence sentiment around its near-term operating outlook. We’ll now examine how this downgrade, rooted in cautious Q1 2026...
NYSE:AES
NYSE:AESRenewable Energy

AES Haven Safety AI Puts Operational Risk And Take Private In Focus

AES (NYSE:AES) has launched Haven Safety AI, described as one of the energy sector's first large-scale AI driven safety platforms. The platform focuses on safety incident investigation and operational risk management across AES's global operations. This move positions AES as an early adopter of AI native tools for workforce safety in the utilities and renewables space. AES, trading at $14.22, is rolling out Haven Safety AI at a time when its long term share performance has been mixed. The...
NYSE:NRG
NYSE:NRGElectric Utilities

A Look At NRG Energy (NRG) Valuation After Leadership Change And Multibillion Dollar Equity Offering

NRG Energy (NRG) just combined a leadership shakeup with fresh capital raising by appointing Caroline Golin, Ph.D., as Chief Growth and Policy Officer and completing a multibillion dollar follow-on equity offering. See our latest analysis for NRG Energy. Those moves come after a busy few days for the stock, with the follow on equity offering at US$164 per share and a 1 day share price return of 2.33% lifting the latest share price to US$152.10. At the same time, the 1 year total shareholder...
NYSE:CRL
NYSE:CRLLife Sciences

Are Charles River’s New Advanced Therapy Deals Quietly Rewriting Its Drug-Development Moat Story (CRL)?

Earlier in March 2026, Locus Cell and Therna Biosciences each announced collaborations with Charles River Laboratories, pairing its global preclinical and analytical expertise with partners’ cell, gene, and RNA therapy platforms across Asia and ultra-rare disease settings. These agreements highlight how Charles River is embedding itself deeper into advanced therapies and personalized RNA medicine workflows, potentially reinforcing its role in high-complexity drug development services. We’ll...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Assessing Pharvaris (PHVS) Valuation After New Real‑World HAE Study Supports Deucrictibant Trials

Pharvaris (NasdaqGS:PHVS) recently released real world data on hereditary angioedema attacks, focusing on how patients report symptoms and improvement. This provides investors with fresh context for its oral deucrictibant program. See our latest analysis for Pharvaris. Following this clinical progress, Pharvaris shares trade at US$26.38, with a 90 day share price return of 9.19% and a 1 year total shareholder return of 56%. This suggests momentum has been building over the longer term despite...
NYSE:LEU
NYSE:LEUOil and Gas

Assessing Centrus Energy (LEU) Valuation After New AI And HALEU Fuel Collaborations

Oklo Inc. and Centrus Energy (LEU) are exploring a joint venture for high assay low enriched uranium deconversion at Centrus’ Piketon, Ohio site, connecting enrichment, advanced fuel services, and U.S. nuclear supply security. See our latest analysis for Centrus Energy. The joint venture talks with Oklo and Centrus Energy’s recent AI partnership with Palantir come against a backdrop of sharp share price swings, with a 7.24% 1 day share price return and 10.59% 7 day share price return...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

A Look At Peloton (PTON) Valuation After EBITDA Gains Guidance Lift And CFO Transition

Peloton Interactive (PTON) is back in focus after a mixed set of financial updates, an increase in profit guidance for fiscal 2026, and the upcoming handover of CFO responsibilities to interim finance chief Saqib Baig. See our latest analysis for Peloton Interactive. Despite the uplift in Adjusted EBITDA guidance and new product launches such as Peloton IQ, the share price has been weak, with a 30 day share price return of 13.33% decline and a 1 year total shareholder return of 37.89%...
NYSE:NHI
NYSE:NHIHealth Care REITs

Will Strong Q4 Beat And Acquisition Capacity Shift National Health Investors' (NHI) Narrative

Recently, National Health Investors reported fourth-quarter 2025 results that exceeded analyst expectations, with revenue coming in well ahead of prior forecasts. Analyst commentary has highlighted that the company’s solid financial position may support future acquisition activity without placing undue pressure on its balance sheet. We’ll now examine how National Health Investors’ stronger-than-expected earnings and acquisition capacity may influence its existing investment narrative. AI is...
NYSE:WMK
NYSE:WMKConsumer Retailing

Weis Markets (WMK) Valuation Check After Q4 And Full Year 2025 Results And Growth Investments

Q4 and full year results in focus Weis Markets (WMK) has drawn investor attention after reporting fourth quarter and full year 2025 results, with higher sales, softer net income and continued investment in pricing, stores, technology and e-commerce capabilities. See our latest analysis for Weis Markets. Weis Markets’ latest results come after a softer patch in the share price, with a 30 day share price return of 12% decline and a 1 year total shareholder return of 17.3% decline. This suggests...
NasdaqGS:SHOO
NasdaqGS:SHOOLuxury

Steven Madden (SHOO) Valuation Check After Volatile Trading And Strong Fourth Quarter Earnings

Steven Madden (SHOO) has been in focus after sharp price swings tied to geopolitical tensions with Iran, a strong fourth quarter earnings beat, and fresh insider selling that sharpened investor attention on the stock. See our latest analysis for Steven Madden. Those sharp swings over the past few days sit on top of a weaker recent trend, with a 30 day share price return of 11.69% decline and a 90 day share price return of 25.22% decline, even though the 1 year total shareholder return of...
NasdaqGS:GRAL
NasdaqGS:GRALBiotechs

Assessing GRAIL (GRAL) Valuation After Recent Share Price Volatility and Narrative Fair Value Gap

Recent performance snapshot GRAIL (GRAL) has drawn attention after a recent slide in its share price, with the stock down about 5% over the past day and posting steeper declines over the past month. See our latest analysis for GRAIL. At a share price of $44.34, GRAIL’s recent 30 day share price return of 57.23% and year to date share price return of 50.11% contrast sharply with a 1 year total shareholder return of 64.71%. This suggests momentum has faded as investors reassess growth prospects...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC) Valuation Check After Strong 48.1% Three Month Share Price Return

Western Digital (WDC) is back on many watchlists after a strong past 3 months, with the stock showing a 48.1% total return, while recent daily and monthly moves have been more mixed. See our latest analysis for Western Digital. At a share price of $261.18, Western Digital’s 48.1% 3 month share price return sits alongside a very large 1 year total shareholder return. This suggests recent momentum has been strong even with a softer 1 day move. If Western Digital’s surge has caught your eye, it...
NYSE:STEL
NYSE:STELBanks

A Look At Stellar Bancorp (STEL) Valuation After Recent Share Price Pullback

With no single headline event driving Stellar Bancorp (STEL) today, the stock’s recent performance and fundamentals, including US$413.252m in revenue and US$102.872m in net income, provide a concise snapshot of its current profile. See our latest analysis for Stellar Bancorp. Stellar Bancorp’s recent share price pullback, including a 9.54% 1 month share price return and 4.23% 7 day share price return, sits against a stronger backdrop. A 16.16% year to date share price return and 34.48% 1 year...
NYSE:PSX
NYSE:PSXOil and Gas

Is It Too Late To Consider Phillips 66 (PSX) After Its Strong Multi Year Rally

Wondering whether Phillips 66 at around US$174 a share is still offering value, or if the easy money has already been made? This article walks through what the numbers actually say about the stock. The share price has recently moved by 4.6% over the last 7 days, 10.7% over 30 days, 33.3% year to date and 47.3% over the past year, which may have changed how investors think about both its upside and its risks. These returns also sit alongside a longer-term picture, with the stock recording a...
NYSE:THR
NYSE:THRElectrical

A Look At Thermon Group Holdings (THR) Valuation After A Strong Year Of Shareholder Returns

Thermon Group Holdings (THR) has caught investor attention after a strong year, with a 64.75% 1 year total return and year to date performance of 23.62% as of the latest close. See our latest analysis for Thermon Group Holdings. The recent 1 month share price return of 7.42% and 1 day move of 0.89% lower sit against a stronger 90 day share price return of 15.64% and 1 year total shareholder return of 63.75%. This suggests momentum has been building despite some near term cooling around the...
NYSE:MDT
NYSE:MDTMedical Equipment

Assessing Medtronic’s Valuation After Strong Q3 2026 Results And Dividend Aristocrat Reaffirmation

Medtronic (MDT) is back in focus after reporting better-than-expected Q3 2026 results, highlighting 6% organic revenue growth and affirming a quarterly dividend of $0.71 per share that extends its dividend aristocrat record. See our latest analysis for Medtronic. Despite the Q3 beat, Medtronic’s recent share price performance has been weak, with a 30 day share price return of 13.84% and a year to date share price return of 9.03%. The 3 year total shareholder return of 21.56% contrasts with a...
NYSE:GRC
NYSE:GRCMachinery

Is It Time To Reassess Gorman-Rupp (GRC) After Its Recent Share Price Pullback

If you are wondering whether Gorman-Rupp at around US$59 a share offers good value today, this article will walk through what the current price actually reflects. The stock is down about 5.6% over the last week and 10.8% over the last month, while still sitting on a 22.9% year-to-date return and a 63.5% return over the past year. Recent attention has focused on Gorman-Rupp as investors reassess companies in the capital goods space, with an eye on how pump and fluid handling businesses are...
NYSE:CIEN
NYSE:CIENCommunications

Ciena (CIEN) Is Up 12.5% After Hiking 2026 Guidance And Showcasing AI Optical Advances – Has The Bull Case Changed?

Earlier in March 2026, Ciena reported first-quarter revenue of US$1,427.04 million and net income of US$150.28 million, raised its full-year 2026 revenue guidance to US$5.90–US$6.30 billion, and completed a US$410.26 million share repurchase program while providing second-quarter revenue guidance of about US$1.50 billion plus or minus US$50 million. Around the same time, Ciena also highlighted advanced optical, AI-oriented, and quantum-secure networking innovations at OFC 2026, underscoring...
NYSE:FCX
NYSE:FCXMetals and Mining

Is Freeport-McMoRan (FCX) Pricing Look Attractive After Strong 1-Year Share Price Jump

If you are wondering whether Freeport McMoRan is offering fair value at its current share price, you are not alone. This article will walk through how that price stacks up against a few common valuation checks. The stock last closed at US$59.21, with returns of 14.0% year to date and 59.7% over the past year, although the price has seen a 5.5% decline over the last 7 days and a 6.4% decline over the past 30 days. Recent market attention on Freeport McMoRan has been shaped by broader interest...
NasdaqGS:SEIC
NasdaqGS:SEICCapital Markets

SEI Investments Moat Underpins Strong Growth Profitability And Undervalued Shares

SEI Investments (NasdaqGS:SEIC) reports sustained strong revenue growth and profitability. The company highlights an outstanding return on equity that points to efficient operations. Management attributes performance to a robust competitive moat in its core investment services and technology offerings. The recent data show annualized revenue and EPS growth running ahead of past averages. SEI Investments, known for its investment processing, asset management, and technology platforms, is...
NYSE:FUL
NYSE:FULChemicals

Reassessing H.B. Fuller (FUL) After Recent Share Price Weakness And DCF Valuation Estimate

If you are wondering whether H.B. Fuller at around US$55.30 is a bargain or just fairly priced, you are not alone. This article is built to help you test that idea with numbers rather than gut feel. The stock has seen a 10.3% decline over the last 7 days, a 16.7% decline over the last 30 days, and is down 8.4% year to date. However, the 1 year return sits at 6.3% and the longer term 3 year and 5 year returns are 12.2% and 3.1% declines respectively. Recent moves in H.B. Fuller shares have...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Weakness

Why Catalyst Pharmaceuticals Stock Is On Investor Radars Catalyst Pharmaceuticals (CPRX) has attracted fresh attention after recent trading left the share price at $23.39, with returns mixed over the past week, month and past 3 months. See our latest analysis for Catalyst Pharmaceuticals. Recent trading weakness, including a 4.16% 1 day share price decline and softer 7 and 30 day share price returns, sits against a stronger backdrop, with 1 year total shareholder return of 12.07% and a very...